{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-10T12:59:00.329657+00:00","published_at":"2026-10-10T04:46:20.080096+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:13c2d5815e41t0","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-30","detected_at":"2026-10-10T04:46:20.080096+00:00","subject_ids":["alpha:person:julie-krop-m-d","alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f"],"caused_claim_ids":["alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:cf40d0eed08203ab59df2e90f6a8b5bd7f851111d0738115456fe78a096933dc"],"summary":"Julie Krop, M.D. executive of DiaMedica Therapeutics Inc., effective 2026-03-30.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:11jemk42zioa8","event_type":"CEO_CHANGED","effective_at":"2026-03-30","detected_at":"2026-10-10T04:46:20.080096+00:00","subject_ids":["alpha:person:rick-pauls","alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f"],"caused_claim_ids":["alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:e3f3e2c9a46691d1f35beb4ca3fa99ca1fbf2a6ff62409f76f628458c440cb2d"],"summary":"Rick Pauls executive of DiaMedica Therapeutics Inc., effective 2026-03-30.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:100cuvqoyb1zs","event_type":"CFO_CHANGED","effective_at":"2026-03-30","detected_at":"2026-10-10T04:46:20.080096+00:00","subject_ids":["alpha:person:scott-kellen","alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f"],"caused_claim_ids":["alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:0149d83920588d3e6a30014b70780cce044093d89f2ebef7e0fd17aaf836c10f"],"summary":"Scott Kellen executive of DiaMedica Therapeutics Inc., effective 2026-03-30.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1wogxv323eg9","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-10T04:46:20.080096+00:00","subject_ids":["alpha:person:daniel-o-connor","alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f"],"caused_claim_ids":["alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3"],"summary":"Daniel O'Connor seat on DiaMedica Therapeutics Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1okr5zgvdei4s","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-10T04:46:20.080096+00:00","subject_ids":["alpha:person:richard-kuntz-m-d-m-sc","alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f"],"caused_claim_ids":["alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3"],"summary":"Richard Kuntz, M.D., M.Sc. seat on DiaMedica Therapeutics Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:nsl71f1os8twh","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-10T04:46:20.080096+00:00","subject_ids":["alpha:person:tanya-lewis","alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f"],"caused_claim_ids":["alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3"],"summary":"Tom Lewis seat on DiaMedica Therapeutics Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:v7dn0d1ask719","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-10-10T04:46:20.080096+00:00","subject_ids":["alpha:committee:diamedica-therapeutics-inc:audit-compensation","alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f"],"caused_claim_ids":["alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3"],"summary":"Audit; Compensation committee of DiaMedica Therapeutics Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1s09o674niv0z","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-10T04:46:20.080096+00:00","subject_ids":["alpha:person:tanya-lewis","alpha:committee:diamedica-therapeutics-inc:audit-compensation"],"caused_claim_ids":["alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3"],"summary":"Tom Lewis member of Audit; Compensation, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:x2fibsk7xrf2","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-10T04:46:20.080096+00:00","subject_ids":["alpha:person:charles-semba-m-d","alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f"],"caused_claim_ids":["alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3"],"summary":"Charles Semba, M.D. seat on DiaMedica Therapeutics Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:amvl3vu494of","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-10-10T04:46:20.080096+00:00","subject_ids":["alpha:person:james-parsons","alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f"],"caused_claim_ids":["alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3"],"summary":"James Parsons seat on DiaMedica Therapeutics Inc., effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:124ll77anr38n","event_type":"COMMITTEE_CREATED","effective_at":"2015-01-01","detected_at":"2026-10-10T04:46:20.080096+00:00","subject_ids":["alpha:committee:diamedica-therapeutics-inc:audit-chair","alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f"],"caused_claim_ids":["alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3"],"summary":"Audit · Chair committee of DiaMedica Therapeutics Inc., effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1p632zm19f8wrs","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2015-01-01","detected_at":"2026-10-10T04:46:20.080096+00:00","subject_ids":["alpha:person:james-parsons","alpha:committee:diamedica-therapeutics-inc:audit-chair"],"caused_claim_ids":["alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3"],"summary":"James Parsons member of Audit · Chair, effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1d3oho9sidhid","event_type":"DIRECTOR_APPOINTED","effective_at":"2010-01-01","detected_at":"2026-10-10T04:46:20.080096+00:00","subject_ids":["alpha:person:michael-giuffre-m-d","alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f"],"caused_claim_ids":["alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3"],"summary":"Michael Giuffre, M.D. seat on DiaMedica Therapeutics Inc., effective 2010-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:h9we4y1vy5obo","event_type":"DIRECTOR_APPOINTED","effective_at":"2005-01-01","detected_at":"2026-10-10T04:46:20.080096+00:00","subject_ids":["alpha:person:rick-pauls","alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f"],"caused_claim_ids":["alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3"],"summary":"Rick Pauls seat on DiaMedica Therapeutics Inc., effective 2005-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:5","subject_id":"alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:charles-semba-m-d","object_label":"Charles Semba, M.D.","object_source_name_forms":[],"value":"Charles Semba, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:charles-semba-m-d","name":"Charles Semba, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-10T04:46:20.080096+00:00","sources":[{"id":"alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DiaMedica Therapeutics Inc. DEF 14A 2026-04-01","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774926010879/dmtp20260331_def14a.htm","source_date":"2026-04-01","retrieved_at":"2026-04-24T23:57:01.126+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-01","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-10T04:46:20.080096+00:00","reviewed_at":"2026-10-10T04:46:20.080096+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:6","subject_id":"alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:daniel-o-connor","object_label":"Daniel O'Connor","object_source_name_forms":[],"value":"Daniel O'Connor: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:daniel-o-connor","name":"Daniel O'Connor"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-10T04:46:20.080096+00:00","sources":[{"id":"alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DiaMedica Therapeutics Inc. DEF 14A 2026-04-01","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774926010879/dmtp20260331_def14a.htm","source_date":"2026-04-01","retrieved_at":"2026-04-24T23:57:01.126+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-01","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-10T04:46:20.080096+00:00","reviewed_at":"2026-10-10T04:46:20.080096+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:7","subject_id":"alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:james-parsons","object_label":"James Parsons","object_source_name_forms":[],"value":"James Parsons: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:james-parsons","name":"James Parsons"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-10T04:46:20.080096+00:00","sources":[{"id":"alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DiaMedica Therapeutics Inc. DEF 14A 2026-04-01","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774926010879/dmtp20260331_def14a.htm","source_date":"2026-04-01","retrieved_at":"2026-04-24T23:57:01.126+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-01","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-10T04:46:20.080096+00:00","reviewed_at":"2026-10-10T04:46:20.080096+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:8","subject_id":"alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-giuffre-m-d","object_label":"Michael Giuffre, M.D.","object_source_name_forms":[],"value":"Michael Giuffre, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-giuffre-m-d","name":"Michael Giuffre, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2010-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2010-01-01","valid_to":null,"recorded_at":"2026-10-10T04:46:20.080096+00:00","sources":[{"id":"alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DiaMedica Therapeutics Inc. DEF 14A 2026-04-01","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774926010879/dmtp20260331_def14a.htm","source_date":"2026-04-01","retrieved_at":"2026-04-24T23:57:01.126+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-01","effective_from":"2010-01-01","effective_until":null,"observed_at":"2026-10-10T04:46:20.080096+00:00","reviewed_at":"2026-10-10T04:46:20.080096+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:9","subject_id":"alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:richard-kuntz-m-d-m-sc","object_label":"Richard Kuntz, M.D., M.Sc.","object_source_name_forms":[],"value":"Richard Kuntz, M.D., M.Sc.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:richard-kuntz-m-d-m-sc","name":"Richard Kuntz, M.D., M.Sc."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-10T04:46:20.080096+00:00","sources":[{"id":"alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DiaMedica Therapeutics Inc. DEF 14A 2026-04-01","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774926010879/dmtp20260331_def14a.htm","source_date":"2026-04-01","retrieved_at":"2026-04-24T23:57:01.126+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-01","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-10T04:46:20.080096+00:00","reviewed_at":"2026-10-10T04:46:20.080096+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:10","subject_id":"alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:rick-pauls","object_label":"Rick Pauls","object_source_name_forms":[],"value":"Rick Pauls: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:rick-pauls","name":"Rick Pauls"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2005-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2005-01-01","valid_to":null,"recorded_at":"2026-10-10T04:46:20.080096+00:00","sources":[{"id":"alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DiaMedica Therapeutics Inc. DEF 14A 2026-04-01","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774926010879/dmtp20260331_def14a.htm","source_date":"2026-04-01","retrieved_at":"2026-04-24T23:57:01.126+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-01","effective_from":"2005-01-01","effective_until":null,"observed_at":"2026-10-10T04:46:20.080096+00:00","reviewed_at":"2026-10-10T04:46:20.080096+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:11","subject_id":"alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:tanya-lewis","object_label":"Tom Lewis","object_source_name_forms":[],"value":"Tom Lewis: Director, Audit; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:tanya-lewis","name":"Tom Lewis"},"title":"Director","role_category":"director","committee":"Audit; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-10T04:46:20.080096+00:00","sources":[{"id":"alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DiaMedica Therapeutics Inc. DEF 14A 2026-04-01","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774926010879/dmtp20260331_def14a.htm","source_date":"2026-04-01","retrieved_at":"2026-04-24T23:57:01.126+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-01","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-10T04:46:20.080096+00:00","reviewed_at":"2026-10-10T04:46:20.080096+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:12","subject_id":"alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:julie-krop-m-d","object_label":"Julie Krop, M.D.","object_source_name_forms":[],"value":"Julie Krop, M.D.: Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:julie-krop-m-d","name":"Julie Krop, M.D."},"title":"Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-30","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-30","valid_to":null,"recorded_at":"2026-10-10T04:46:20.080096+00:00","sources":[{"id":"alpha:projection-evidence:document:cf40d0eed08203ab59df2e90f6a8b5bd7f851111d0738115456fe78a096933dc","identity_scope":"source_document_reference","source_type":"sec_filing","title":"DMAC 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774926010342/dmtp20251231_10k.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T01:32:03.433743+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30T00:00:00+00:00","effective_from":"2026-03-30","effective_until":null,"observed_at":"2026-10-10T04:46:20.080096+00:00","reviewed_at":"2026-10-10T04:46:20.080096+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:13","subject_id":"alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:rick-pauls","object_label":"Rick Pauls","object_source_name_forms":[],"value":"Rick Pauls: President and Chief Executive Officer, Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:rick-pauls","name":"Rick Pauls"},"title":"President and Chief Executive Officer, Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-30","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-30","valid_to":null,"recorded_at":"2026-10-10T04:46:20.080096+00:00","sources":[{"id":"alpha:projection-evidence:document:e3f3e2c9a46691d1f35beb4ca3fa99ca1fbf2a6ff62409f76f628458c440cb2d","identity_scope":"source_document_reference","source_type":"sec_filing","title":"DMAC 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774926010342/dmtp20251231_10k.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T01:32:03.071781+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30T00:00:00+00:00","effective_from":"2026-03-30","effective_until":null,"observed_at":"2026-10-10T04:46:20.080096+00:00","reviewed_at":"2026-10-10T04:46:20.080096+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:14","subject_id":"alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:scott-kellen","object_label":"Scott Kellen","object_source_name_forms":[],"value":"Scott Kellen: Chief Financial Officer and Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:scott-kellen","name":"Scott Kellen"},"title":"Chief Financial Officer and Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-30","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-30","valid_to":null,"recorded_at":"2026-10-10T04:46:20.080096+00:00","sources":[{"id":"alpha:projection-evidence:document:0149d83920588d3e6a30014b70780cce044093d89f2ebef7e0fd17aaf836c10f","identity_scope":"source_document_reference","source_type":"sec_filing","title":"DMAC 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774926010342/dmtp20251231_10k.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T01:32:03.884353+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30T00:00:00+00:00","effective_from":"2026-03-30","effective_until":null,"observed_at":"2026-10-10T04:46:20.080096+00:00","reviewed_at":"2026-10-10T04:46:20.080096+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DiaMedica Therapeutics Inc. DEF 14A 2026-04-01","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774926010879/dmtp20260331_def14a.htm","source_date":"2026-04-01","retrieved_at":"2026-04-24T23:57:01.126+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:cf40d0eed08203ab59df2e90f6a8b5bd7f851111d0738115456fe78a096933dc","identity_scope":"source_document_reference","source_type":"sec_filing","title":"DMAC 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774926010342/dmtp20251231_10k.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T01:32:03.433743+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:e3f3e2c9a46691d1f35beb4ca3fa99ca1fbf2a6ff62409f76f628458c440cb2d","identity_scope":"source_document_reference","source_type":"sec_filing","title":"DMAC 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774926010342/dmtp20251231_10k.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T01:32:03.071781+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:0149d83920588d3e6a30014b70780cce044093d89f2ebef7e0fd17aaf836c10f","identity_scope":"source_document_reference","source_type":"sec_filing","title":"DMAC 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774926010342/dmtp20251231_10k.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T01:32:03.884353+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.843,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.863,"cross_source_agreement":0.75,"temporal_completeness":0.769},"diagnostics":{"published_claims":19,"factual_claims":19,"claims_with_linked_evidence":19,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":13,"temporal_claims_with_valid_from":10,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-10T04:46:20.080096+00:00","observed_at":"2026-10-10T04:46:20.080096+00:00","reviewed_at":"2026-10-10T04:46:20.080096+00:00","verified_at":"2026-10-10T04:46:20.080096+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":19,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/diamedica-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}